Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | -99.89%2.5K | -109.20%-20K | 0 | -96.54%22.5K | 0 | 235.28%2.2M | -51.12%217.49K | 196,451.74%676.14K | 792.12%650.7K |
| Operating revenue | --0 | -99.89%2.5K | -109.20%-20K | --0 | -96.54%22.5K | --0 | 235.28%2.2M | -51.12%217.49K | 196,451.74%676.14K | 792.12%650.7K |
| Cost of revenue | -99.35%2.3K | -154.37%-18.95K | 0 | -77.95%21.25K | 0 | 220.29%351.95K | -45.75%34.86K | 426.18%124.35K | 361.69%96.37K | |
| Gross profit | -99.99%200 | -100.57%-1.05K | 0 | -99.77%1.25K | 0 | 238.30%1.84M | -52.03%182.64K | 2,469.42%551.79K | 964.68%554.33K | |
| Operating expense | -62.26%113.43K | -37.35%808.07K | -64.42%176.45K | -50.71%216.67K | -22.23%114.37K | 24.07%300.58K | -78.45%1.29M | -13.75%495.99K | -14.96%439.59K | -94.11%147.06K |
| Selling and administrative expenses | -58.27%83.62K | -29.03%626.02K | -54.80%162.42K | -34.14%206.88K | -13.94%56.33K | 35.89%200.4K | -81.04%882.06K | 40.80%359.3K | -9.55%314.11K | -96.82%65.45K |
| -Selling and marketing expense | -98.43%330 | -35.42%44.14K | -98.65%660 | --0 | 32,988.24%22.5K | 119.15%20.98K | -85.02%68.36K | 2,129.32%49.05K | -0.91%9.67K | -99.98%68 |
| -General and administrative expense | -53.58%83.29K | -28.49%581.88K | -47.86%161.76K | -32.04%206.88K | -48.27%33.83K | 30.11%179.42K | -80.61%813.71K | 22.64%310.25K | -9.80%304.44K | -96.13%65.38K |
| Research and development costs | --0 | 46.51%40.2K | -30.94%18.95K | --0 | --189 | --21.06K | -80.40%27.44K | 586.22%27.44K | --0 | --0 |
| Depreciation amortization depletion | ---- | --0 | --0 | --0 | --0 | --0 | -62.85%112.19K | -8.10%44.84K | -51.84%40.64K | -92.57%6.27K |
| -Depreciation and amortization | ---- | --0 | --0 | --0 | --0 | --0 | -62.85%112.19K | -8.10%44.84K | -51.84%40.64K | -92.57%6.27K |
| Other operating expenses | -62.33%29.8K | -47.10%141.85K | -107.63%-4.92K | -88.46%9.79K | -23.20%57.86K | 6.41%79.12K | -69.86%268.15K | -75.88%64.42K | -0.50%84.84K | -74.63%75.34K |
| Operating profit | 62.26%-113.43K | -245.79%-807.87K | 43.36%-177.5K | -293.11%-216.67K | -127.78%-113.12K | -196.05%-300.58K | 110.19%554.12K | -61.27%-313.35K | 120.77%112.2K | 116.65%407.27K |
| Net non-operating interest income (expenses) | 0 | 70.06%-16.23K | -547.72%-17.47K | 0 | 0 | 103.67%1.24K | 52.30%-54.21K | 93.95%-2.7K | 86.46%-4.15K | 53.84%-13.71K |
| Non-operating interest income | --0 | --1.24K | --0 | --0 | --0 | --1.24K | --0 | --0 | --0 | --0 |
| Non-operating interest expense | ---- | -67.78%17.47K | 547.72%17.47K | --0 | --0 | --0 | -60.76%54.21K | -95.70%2.7K | -88.78%4.15K | -53.84%13.71K |
| Other net income (expenses) | 83.36%-85.55K | 92.47%-514.26K | 36.51%-702.53K | 104.29%95.81K | 103.17%110.55K | |||||
| Special income (charges) | ---- | 83.36%-85.55K | 87.72%-85.55K | --0 | --0 | --0 | 92.44%-514.26K | 35.28%-696.51K | 104.28%95.81K | 103.17%110.55K |
| -Less:Impairment of capital assets | ---- | --0 | ---- | ---- | --0 | ---- | -89.44%696.51K | -42.27%696.51K | --0 | -100.17%-6.02K |
| -Less:Other special charges | ---- | 145.57%83.05K | ---- | ---- | ---- | ---- | 17.34%-182.26K | --0 | -254.85%-95.81K | ---104.53K |
| -Less:Write off | ---- | --2.5K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Gain on sale of business | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- |
| Income before tax | 62.11%-113.43K | -6,241.25%-909.65K | 72.46%-280.51K | -206.28%-216.67K | -122.44%-113.12K | -201.04%-299.34K | 99.88%-14.35K | 24.30%-1.02M | 107.27%203.86K | 108.45%504.11K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 62.11%-113.43K | -6,241.25%-909.65K | 72.46%-280.51K | -206.28%-216.67K | -122.44%-113.12K | -201.04%-299.34K | 99.89%-14.35K | 21.96%-1.02M | 107.18%203.86K | 108.33%504.11K |
| Net income continuous operations | 62.11%-113.43K | -6,241.25%-909.65K | 72.46%-280.51K | -206.28%-216.67K | -122.44%-113.12K | -201.04%-299.34K | 99.88%-14.35K | 24.30%-1.02M | 107.27%203.86K | 108.45%504.11K |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 62.11%-113.43K | -6,241.25%-909.65K | 72.46%-280.51K | -206.28%-216.67K | -122.44%-113.12K | -201.04%-299.34K | 99.89%-14.35K | 21.96%-1.02M | 107.18%203.86K | 108.33%504.11K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 62.11%-113.43K | -6,241.25%-909.65K | 72.46%-280.51K | -206.28%-216.67K | -122.44%-113.12K | -201.04%-299.34K | 99.89%-14.35K | 21.96%-1.02M | 107.18%203.86K | 108.33%504.11K |
| Diluted earnings per share | 66.67%-0.01 | -0.09 | 91.38%-0.01 | -200.00%-0.04 | 0 | -105.00%-0.03 | 0 | 91.94%-0.116 | 100.64%0.04 | 100.89%0.12 |
| Basic earnings per share | 66.67%-0.01 | -0.09 | 91.38%-0.01 | -0.04 | 0 | -105.00%-0.03 | 0 | 91.94%-0.116 | 0 | 100.60%0.08 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.